Multiple Companies Report, Plan First Quarter Financial Results

Various companies, including NIS Group, Novacyt S.A., and YANGAROO Inc., have announced their first-quarter financial results. Lexicon Pharmaceuticals also confirmed its plans to report its Q1 2026 earnings on May 7.

30 Apr, 13:53 — 30 Apr, 15:35

Post Share

Why this matters

First-quarter financial results provide crucial insights into a company's performance and financial health, influencing investor decisions and market perceptions. These reports reflect the impact of recent economic conditions and strategic initiatives on corporate profitability and growth.

Key entitiesNIS grupa Novacyt S.A.Lexicon Pharmaceuticals

The Story

What 3 sources agree on, dispute, and miss

Key claims5 unverified

NIS Group achieved sales revenue of 66.2 billion dinars for the first three months of 2026.

unverified·n1-serbia

NIS Group reported a net profit of 2.8 billion dinars for the first three months of 2026.

unverified·n1-serbia

Novacyt S.A. reported GAAP EPS of -£0.32.

unverified·seeking-alpha

Novacyt S.A. reported revenue of £20M.

unverified·seeking-alpha

Lexicon Pharmaceuticals will report its First Quarter 2026 Financial Results on May 7, 2026.

unverified·globe-and-mail

Coverage gaps

Detailed financial figures for NIS Group, including sales revenue and net profit in Serbian Dinars

Reportedn1-serbia

Missingseeking-alphaglobe-and-mail

Specific GAAP EPS and revenue figures for Novacyt S.A.

Reportedseeking-alpha

Missingn1-serbiaglobe-and-mail

Announcement of Lexicon Pharmaceuticals' upcoming Q1 2026 earnings report date

Reportedglobe-and-mail

Missingn1-serbiaseeking-alpha

The Story

Analyzing sources…

Source Diversity

Moderate (46/100)

3 sources25/33

Spectrum spread— 2/5 buckets covered8/33

Far L

Left2

Left (2)

n1-serbiaglobe-and-mail

Center

Right1

Right (1)

seeking-alpha

Far R

Geographic diversity— 3 regions13/34

Serbia1US1Canada1

Sources

Showing 2 of 3 sources

globe-and-mailHigh4h ago

Lexicon Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026 - The Globe and Mail

Lexicon Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026 The Globe and Mail

Read full article →

seeking-alphaMixed2h ago

Novacyt S.A. GAAP EPS of -£0.32, revenue of £20M

Read full article →

Coverage Timeline

First report: globe-and-mail · 30 Apr, 13:53|Full coverage: 3 · 3h|Window: 3h

Left-leaningCenterRight-leaning

globe-and-mail30 Apr, 13:53First to report

Lexicon Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026 - The Globe and Mail

2h later

seeking-alpha30 Apr, 15:35

Novacyt S.A. GAAP EPS of -£0.32, revenue of £20M

1h later

n1-serbia30 Apr, 16:42Latest update

PERSPECTA

PERSPECTA

Multiple Companies Report, Plan First Quarter Financial Results

Why this matters

The Story

Key claims5 unverified

Coverage gaps

The Story

Source Diversity

Source Diversity

Sources

Lexicon Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026 - The Globe and Mail

Novacyt S.A. GAAP EPS of -£0.32, revenue of £20M

Coverage Timeline

Lexicon Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026 - The Globe and Mail

Novacyt S.A. GAAP EPS of -£0.32, revenue of £20M

NIS grupa objavila poslovne rezultate za prva tri meseca 2026: Ostvarena neto dobit od 2,8 milijardi dinara

Related Stories

Oil Jumps Above $100 After US-Iran Talks Fail

Saudi Arabia's PIF to Reduce LIV Golf Funding Amid Economic Turmoil

Philippine Deputy Speaker Discusses Government Underspending

Wells Fargo Analyst Suggests AI Investing Cycle Reaching Inflection Point

PERSPECTA

Why this matters

The Story

Key claims5 unverified

Coverage gaps

Coverage matrix